Hydroxocobalamin and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxocobalamin (hydroxocobalamin) and Ezetimibe (ezetimibe). Common drug interactions include gastrointestinal haemorrhage among females and hypoglycaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxocobalamin and Ezetimibe. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxocobalamin?

Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 4,273 Hydroxocobalamin users. Check the latest studies of Hydroxocobalamin.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.



On Jul, 10, 2026

89 people who take Hydroxocobalamin and Ezetimibe together, and have interactions are studied.

Hydroxocobalamin and Ezetimibe drug interactions.

What are the common drug interactions of Hydroxocobalamin and Ezetimibe, by gender? *:

female:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Haemoglobin decreased
  3. Dyspnoea (difficult or laboured respiration)
  4. Myalgia (muscle pain)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Rash
  7. Angina pectoris (chest pain due to ischemia of the heart muscle)
  8. Diarrhoea
  9. Constipation
  10. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)

male:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  3. Rash
  4. Sleep disorder
  5. Angiopathy (generic term for a disease of the blood vessels)
  6. Dyspnoea (difficult or laboured respiration)
  7. Fatigue (feeling of tiredness)
  8. General physical health deterioration (weak health status)
  9. Peripheral swelling
  10. Blood pressure increased

What are the common drug interactions of Hydroxocobalamin and Ezetimibe, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Constipation
  2. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  3. Pancreatitis acute (sudden inflammation of pancreas)
  4. Abdominal pain
  5. Diarrhoea
  6. Haemoglobin decreased
  7. Nausea (feeling of having an urge to vomit)

50-59:

  1. Myalgia (muscle pain)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Rash
  4. Abdominal pain
  5. Lip swelling
  6. Muscular weakness (muscle weakness)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Blood creatinine increased
  4. Dizziness
  5. Lip swelling
  6. Oral mucosal blistering (mouth ulcer)
  7. Pruritus (severe itching of the skin)
  8. Rash
  9. Sleep disorder
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

  1. Gout (uric acid crystals building up in the body): 10 people, 11.24%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 10.11%
  3. Oropharyngeal Pain: 6 people, 6.74%
  4. High Blood Pressure: 6 people, 6.74%
  5. Pain: 5 people, 5.62%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxocobalamin and Ezetimibe?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Hydroxocobalamin and Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hydroxocobalamin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxocobalamin and ezetimibe (the active ingredients of Hydroxocobalamin and Ezetimibe, respectively), and Hydroxocobalamin and Ezetimibe (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: